Search the Newsreel

Medallion Metals (ASX:MM8) Shares up Nearly 8% Today, Lounge Lizard Gold Mineralisation Results in Focus

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

HUTCHMED (China) Limited — First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO® as the backbone therapy across EGFRm lung cancer — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., …

After TAGRISSO, 338 lung-cancer patients tested a combination—what happened?

HUTCHMED's global Phase III SAFFRON trial showed that ORPATHYS® plus TAGRISSO® significantly improved progression-free and overall survival in patients with MET-driven EGFR-mutated advanced NSCLC after their disease progressed on TAGRISSO®. The combination's safety profile was consistent with known profiles of each medicine, with no …

HUTCHMED Reports Positive Phase III SAFFRON Results for ORPATHYS Plus TAGRISSO in EGFR-Mutated NSCLC

HUTCHMED announced positive results from the SAFFRON Phase III trial for ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) in EGFR-mutated non-small cell lung cancer (NSCLC) patients with MET overexpression or amplification. The combination significantly improved progression-free and overall survival compared to platinum-based chemotherapy. These results mark …

Upgraded 2026 Earnings Guidance After Softer Q2 Might Change The Case For Investing In ICU Medical (ICUI)

Is TransMedics Group (TMDX) Fairly Valued As Revenue Grew And 2026 Guidance Was Raised?

Dr. Sulaiman Al-Habib Medical Services Group Co. Financial Disclosures & Filings

Q & M Dental to Sell Majority Stake in AI Unit to Medi Lifestyle

Medtronic (MDT) Faces Fresh Scrutiny On $88 Million Verdict As Fair Value Stays In Focus

Medtronic (MDT) is under scrutiny after a federal jury ordered it to pay US$88 million for hernia mesh products, a verdict the company plans to challenge. Despite this, Medtronic's stock has seen recent improvements, though its one-year return remains muted. The article discusses Medtronic's …

Understanding Momentum Shifts in (RSVR)

This article analyzes Reservoir Media Inc. (NASDAQ: RSVR) with a focus on momentum shifts, identifying weak near and mid-term sentiment but a strong long-term outlook. It presents three AI-generated trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss …

SBC Medical Group Holdings Incorporated Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI

Walleye Capital LLC has made a new investment of $719,000 in Sanara MedTech Inc. (NASDAQ:SMTI), acquiring 30,465 shares, which represents about 0.33% of the company. Despite institutional investors collectively owning 8.10% of SMTI, analyst sentiment has weakened with several downgrades to "Hold" or "Neutral," …

S&CO Inc. Invests $6.40 Million in Revolution Medicines, Inc. $RVMD

S&CO Inc. recently invested $6.4 million in Revolution Medicines, Inc. (NASDAQ:RVMD) by purchasing 34,171 shares, contributing to institutional ownership of 94.34%. Despite a larger-than-expected quarterly loss, analysts maintain a "Moderate Buy" rating with a consensus price target of $161.79. Insider transactions show mixed activity, …

State of Wyoming Buys Shares of 9,446 Revolution Medicines, Inc. $RVMD

The State of Wyoming recently acquired 9,446 shares of Revolution Medicines, Inc. (NASDAQ:RVMD) valued at approximately $1.77 million, marking a new position in the biopharmaceutical company. This move comes as institutional investors and hedge funds collectively hold 94.34% of RVMD's stock. Despite a recent …

Die Medtronic-Aktie steigt nach Zulassungsschub und solider Prognose

Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)?

DJT Stock Slips After Hours: Trump Media Reports $238M Q2 Loss Driven By Crypto Volatility

Kornitzer Capital Management Inc. KS Reduces Position in Medtronic PLC $MDT

Kornitzer Capital Management Inc. KS reduced its stake in Medtronic PLC (NYSE:MDT) by 15.6% in the second quarter, now owning 103,155 shares valued at $8.07 million. Other institutional investors also adjusted their positions, and analysts have issued various ratings and price targets for MDT. …

Lecap Asset Management Ltd. Invests $1.13 Million in Medtronic PLC $MDT

Lecap Asset Management Ltd. recently purchased a new position in Medtronic PLC (NYSE:MDT), acquiring 14,453 shares valued at approximately $1.13 million during the second quarter. Other institutional investors like Brighton Jones LLC and Main Street Financial Solutions LLC also increased their stakes in Medtronic, …

Zhang Financial LLC Buys 12,259 Shares of Medtronic PLC $MDT

Zhang Financial LLC increased its stake in Medtronic PLC (NYSE:MDT) by 27.4% in the second quarter, acquiring an additional 12,259 shares and bringing its total holdings to 56,984 shares valued at $4,458,000. This move is part of broader institutional investment trends, with several other …

Royal Bank of Canada Has $2.95 Million Stock Holdings in Versant Corporation $VSNT

Royal Bank of Canada significantly increased its stake in Versant Corporation (NASDAQ:VSNT) by purchasing an additional 79,802 shares, bringing its total holdings to 79,805 shares valued at approximately $2.95 million. Despite this substantial investment, Wall Street analysts maintain a neutral stance with an average …

Q&M to become Medi Lifestyle's second-largest shareholder with deal to sell 60% of EM2AI for $6.76 mil

Did Strong Q2 Results, Dividend Hike, and Jets Deal Just Shift OUTFRONT Media's (OUT) Investment Narrative?

OUTFRONT Media Inc. reported strong Q2 2026 results with increased sales and net income, a higher quarterly dividend of US$0.33 per share, and a new advertising deal with the New York Jets. These developments are seen as potentially shifting the company's investment narrative by …

Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of "Moderate Buy" by Analysts

Cooke & Bieler LP Cuts Stake in Medtronic PLC $MDT

Cooke & Bieler LP reduced its stake in Medtronic PLC by 1.6% in the second quarter, selling 12,822 shares but still retaining 799,208 shares valued at $62.5 million. Institutional investors hold a significant 82.06% of Medtronic's stock. Despite some lowered price targets from analysts, …

Number of shareholders of Twareat Medical Care Co. – TADAWUL:9627

ICU Medical, Inc. (NASDAQ:ICUI) Given Average Rating of "Moderate Buy" by Brokerages

ICU Medical, Inc. (NASDAQ:ICUI) has received a "Moderate Buy" consensus rating from nine analysts, with an average 12-month price target of $192.80. The company recently surpassed quarterly earnings and revenue expectations, reporting $2.37 EPS on $547.88 million in revenue, and provided fiscal 2026 EPS …

9,840 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB recently acquired 9,840 shares of Praxis Precision Medicines (NASDAQ:PRAX) valued at approximately $3.29 million, contributing to institutional investors owning 67.84% of the company. Praxis Precision Medicines reported a smaller-than-expected quarterly loss of $2.87 per share and holds a consensus "Buy" rating …

Trump Media Executive Sells Shares Amid Losses

Trump Media's General Counsel, Scott Glabe, sold 25,546 shares for $212,543 on August 13 to cover tax obligations related to equity awards. This non-discretionary sale highlights the company's severe financial strain, including a $1.3 billion net loss over the past year and a 54% …

What Investors Should Know About This Trump Media Insider Filing

General Counsel Scott Glabe of Trump Media & Technology Group (NASDAQ:DJT) disposed of 25,546 shares valued at approximately $213,000 on August 13. This non-discretionary transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock units and does not reflect …

Ascentis Independent Advisors Sells 11,711 Shares of Medtronic PLC $MDT

Ascentis Independent Advisors significantly reduced its stake in Medtronic PLC by 93.6%, selling 11,711 shares and retaining 803 shares valued at $63,000. Medtronic, a global medical technology company, recently reported strong quarterly revenues of $9.81 billion and adjusted earnings of $1.55 per share, surpassing …

Medi Lifestyle Moves into Dental AI with Planned 60% Stake in EM2AI